esmolol has been researched along with Endotoxin Shock in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 27 (72.97) | 24.3611 |
| 2020's | 10 (27.03) | 2.80 |
| Authors | Studies |
|---|---|
| Balaji, L; Berg, K; Chase, M; Cocchi, MN; Dargin, J; Donnino, MW; Grossestreuer, A; Liu, X; Moskowitz, A; Patel, PV | 1 |
| Cai, K; Hou, B; Hu, C; Li, Y; Pu, X | 1 |
| Chen, C; Liu, Y; Yang, J; Yang, X; Yang, Y; Zhang, J | 1 |
| Gao, X; He, Z; Li, T; Wang, J; Xu, G | 1 |
| Cheng, Z; He, S; Ma, Y; Wang, W; Wei, C; Yang, J; Zheng, Y; Zhou, X | 1 |
| Guo, Y; Li, J; Li, Y; Ren, Y; Sun, W; Yang, Z | 1 |
| Lemson, J; Rongen, GA; van der Hoeven, JG; van Loon, LM; Veltink, PH | 1 |
| Carrara, M; Ferrario, M; Herpain, A; Niccolo, A | 1 |
| Carrara, M; Ferrario, M; Herpain, A | 1 |
| Duarte, K; Fritz, C; Girerd, N; Guerci, P; Kimmoun, A; Levy, B; Morelli, A; Piona, C | 1 |
| Du, W; Liu, D; Long, Y; Wang, X | 1 |
| Feng, M; Liu, P; Tang, Y; Wu, Q; Zhou, Z | 1 |
| Allaouchiche, B; Ayoub, JY; Bonnet-Garin, JM; Boselli, E; Bouvet, L; Dauwalder, O; Jacquet-Lagrèze, M; Junot, S; Mansour, C; Margez, T; Paquet, C; Restagno, D | 1 |
| Lemson, J; van der Hoeven, JG; van Loon, LM; Veltink, PH | 1 |
| Balakrishnan, A; Beer, KS; Hart, SK | 1 |
| Brown, SM; Gong, M; Lanspa, M; Paine, R | 1 |
| Cecchini, V; D'Egidio, A; Donati, A; Ertmer, C; Kampmeier, T; Landoni, G; Mebazaa, A; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Singer, M; Venditti, M; Westphal, M | 1 |
| Enkhbaatar, P | 1 |
| Pinsky, MR | 1 |
| D'Egidio, A; D'Ippoliti, F; Ertmer, C; Girardis, M; Guarracino, F; Kampmeier, T; Ligges, S; Mebazaa, A; Morelli, A; Orecchioni, A; Pietropaoli, P; Raffone, C; Rehberg, S; Singer, M; Tritapepe, L; Venditti, M; Westphal, M | 1 |
| McNeilly, RG | 1 |
| Hou, B; Liu, J; Liu, Z; Shi, Q; Yang, S; Yang, W; Zhang, G | 1 |
| Al Kattani, N; Delemazure, J; Dessales, N; Issa, K; Kimmoun, A; Levy, B; Louis, H; Marie, PY; Wei, C | 1 |
| Allaouchiche, B; Ayoub, JY; Bonnet, JM; Dauwalder, O; Etienne, J; Jacquet-Lagrèze, M; Junot, S; Paquet, C; Restagno, D; Vandenesch, F | 1 |
| Foex, P; Morelli, A; Sanfilippo, F; Santonocito, C | 1 |
| DellaVolpe, JD; Moore, JE; Pinsky, MR | 1 |
| Hongki, Z; Juhao, Z; Miaoyun, W; Shenglong, C; Weiping, H; Wenqiang, J; Wenxin, Z; Xinqiang, L | 1 |
| Biondi-Zoccai, G; D'Egidio, A; Frati, G; Greco, E; Guarracino, F; Mascia, L; Morelli, A; Orecchioni, A; Peruzzi, M; Piscioneri, F; Ranieri, VM; Romano, SM; Singer, M | 1 |
| Jingyi, W; Tao, Y; Weihua, L; Xiaogan, J; Xiaoju, J | 1 |
| Du, W; Liu, DW; Long, Y; Wang, XT | 1 |
| Achurra, P; Alegría, L; Bakker, J; Bruhn, A; Castro, R; Gomez, J; Hernández, G; Jarufe, N; Kattan, E; Luengo, C; Ospina-Tascón, G; Rebolledo, R; Soto, D; Tapia, P | 1 |
| Chen, K; Chen, W; Gong, S; Lian, F; Shang, X; Wang, K; Xu, J; Ye, Y; Yu, R | 1 |
| Albuisson, E; Kimmoun, A; Levy, B; Louis, H; Orlowski, S; Schmitt, M; Wei, C | 1 |
| Bissell, BD; Ferreira, JA | 1 |
| Aboab, J; Annane, D; Gharbi, M; Jourdain, M; Mangalaboyi, J; Mansart, A; Sebille, V | 1 |
| Balik, M; Bartakova, H; Korinek, J; Leden, P; Otahal, M; Rulisek, J; Zakharchenko, M | 1 |
7 review(s) available for esmolol and Endotoxin Shock
| Article | Year |
|---|---|
Benefits of esmolol in adults with sepsis and septic shock: An updated meta-analysis of randomized controlled trials.
Topics: Adult; Humans; Propanolamines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Prognosis of β-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies.
Topics: Adrenergic beta-1 Receptor Antagonists; Catecholamines; Heart Failure; Hemodynamics; Humans; Prognosis; Propanolamines; Sepsis; Shock, Septic | 2020 |
The influence of esmolol on septic shock and sepsis: A meta-analysis of randomized controlled studies.
Topics: Adrenergic beta-1 Receptor Antagonists; Humans; Propanolamines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Treatment Outcome | 2018 |
Beta-blocker use in severe sepsis and septic shock: a systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Heart Rate; Hemodynamics; Humans; Metoprolol; Propanolamines; Sepsis; Shock, Septic | 2015 |
Arterial blood pressure and heart rate regulation in shock state.
Topics: Adrenergic beta-1 Receptor Antagonists; Blood Pressure Determination; Critical Care; Heart Rate; Humans; Hypertension; Patient Selection; Propanolamines; Resuscitation; Shock, Septic; Tachycardia | 2015 |
Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Catecholamines; Clonidine; Dexmedetomidine; Humans; Propanolamines; Sepsis; Shock, Septic; Stroke Volume; Sympathetic Nervous System; Sympatholytics; Tachycardia | 2018 |
10 trial(s) available for esmolol and Endotoxin Shock
| Article | Year |
|---|---|
Esmolol to Treat the Hemodynamic Effects of Septic Shock: A Randomized Controlled Trial.
Topics: C-Reactive Protein; Hemodynamics; Humans; Norepinephrine; Propanolamines; Shock, Septic; Tachycardia; Vasoconstrictor Agents | 2022 |
Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography-a randomized controlled trial.
Topics: Cardiomyopathies; Echocardiography; Humans; Prospective Studies; Sepsis; Shock, Septic; Stroke Volume; Ventricular Function, Left | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Animals, Newborn; Cardiac Output; Cardiopulmonary Resuscitation; Heart Rate; Hemodynamics; Monitoring, Physiologic; Nociception; Propanolamines; Prospective Studies; Pseudomonas Infections; Random Allocation; Shock, Septic; Swine; Swine Diseases | 2018 |
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Aged; Dose-Response Relationship, Drug; Female; Heart; Heart Rate; Hemodynamics; Humans; Intensive Care Units; Male; Middle Aged; Norepinephrine; Propanolamines; Shock, Septic; Stroke Volume; Survival Analysis; Treatment Outcome | 2013 |
[Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
Topics: Adrenergic beta-Antagonists; Arterial Pressure; Cardiac Output; Central Venous Pressure; Heart Diseases; Hemodynamics; Humans; Propanolamines; Prospective Studies; Shock, Septic; Stroke Volume; Treatment Outcome | 2014 |
[Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate].
Topics: Arterial Pressure; Central Venous Pressure; Heart Rate; Hemodynamics; Humans; Intensive Care Units; Length of Stay; Norepinephrine; Oximetry; Oxygen; Propanolamines; Prospective Studies; Shock, Septic; Stroke Volume | 2015 |
Efficacy and Safety of Esmolol in Treatment of Patients with Septic Shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Cardiac Output; Echocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Propanolamines; Shock, Septic; Stroke Volume | 2016 |
The Effect of Esmolol on Tissue Perfusion and Clinical Prognosis of Patients with Severe Sepsis: A Prospective Cohort Study.
Topics: Adult; Aged; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Perfusion; Prognosis; Propanolamines; Prospective Studies; Severity of Illness Index; Shock, Septic | 2016 |
Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Shock, Septic; Treatment Outcome | 2012 |
21 other study(ies) available for esmolol and Endotoxin Shock
| Article | Year |
|---|---|
Evaluation of efficacy and safety of esmolol in treating patients with septic shock: A protocol for systematic review and meta-analysis.
Topics: Humans; Meta-Analysis as Topic; Propanolamines; Research Design; Shock, Septic; Systematic Reviews as Topic; Treatment Outcome | 2022 |
LOW DOSE OF ESMOLOL ATTENUATES SEPSIS-INDUCED IMMUNOSUPPRESSION VIA MODULATING T-LYMPHOCYTE APOPTOSIS AND DIFFERENTIATION.
Topics: Animals; Apoptosis; Caspase 3; CD4-Positive T-Lymphocytes; Cell Differentiation; Hypotension; Immunosuppression Therapy; Leukocytes, Mononuclear; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Sepsis; Shock, Septic | 2023 |
β-Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Animals; Female; Heart Rate; Infusions, Intravenous; Lipopolysaccharides; Propanolamines; Renal Circulation; Sheep; Shock, Septic | 2019 |
Reducing tachycardia in septic shock patients: do esmolol and ivabradine have a chronotropic effect only?
Topics: Animals; Humans; Ivabradine; Propanolamines; Shock, Septic; Swine; Tachycardia | 2020 |
Tachycardia control in septic shock with esmolol and ivabradine: a comparison on heart function.
Topics: Animals; Humans; Ivabradine; Propanolamines; Shock, Septic; Swine; Tachycardia | 2020 |
Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cardiac Output; Echocardiography; Female; France; Heart Rate; Hemodynamics; Humans; Indocyanine Green; Male; Middle Aged; Monitoring, Physiologic; Norepinephrine; Pilot Projects; Propanolamines; Shock, Septic; Spectrophotometry, Infrared; Time Factors; Vasoconstrictor Agents | 2021 |
The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dogs; Echocardiography; Endotoxemia; Female; Hemodynamics; Male; Norepinephrine; Propanolamines; Random Allocation; Shock, Septic | 2017 |
The influence of esmolol on right ventricular function in early experimental endotoxic shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Female; Lipopolysaccharides; Propanolamines; Sheep; Shock, Septic; Ventricular Function, Right | 2018 |
Successful management of persistent tachycardia using esmolol in 2 dogs with septic shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Digestive System Surgical Procedures; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Norepinephrine; Postoperative Complications; Propanolamines; Shock, Septic; Tachycardia, Supraventricular; Vasoconstrictor Agents | 2019 |
Value beyond the
Topics: Feasibility Studies; Heart Rate; Hemodynamics; Humans; Pilot Projects; Propanolamines; Shock, Septic | 2019 |
Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Comorbidity; Female; Heart Rate; Hospitals, University; Humans; Intensive Care Units; Male; Microcirculation; Middle Aged; Pilot Projects; Propanolamines; Prospective Studies; Shock, Septic; Stroke Volume; Young Adult | 2013 |
Beta-1 blockade in sepsis: what to expect?
Topics: Adrenergic beta-1 Receptor Antagonists; Female; Heart Rate; Humans; Male; Microcirculation; Propanolamines; Shock, Septic | 2013 |
Is there a role for β-blockade in septic shock?
Topics: Adrenergic beta-1 Receptor Antagonists; Female; Heart Rate; Humans; Male; Propanolamines; Shock, Septic | 2013 |
Sepsis, venous return, and teleology.
Topics: Algorithms; Blood Pressure; Cardiac Output; Coronary Circulation; Critical Illness; Dihydroergotamine; Dobutamine; Heart Rate; Hemodynamics; Humans; Milrinone; Models, Cardiovascular; Norepinephrine; Propanolamines; Shock, Septic; Tilt-Table Test; Vascular Resistance | 2014 |
β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Drug Therapy, Combination; Hemodynamics; Inflammation Mediators; Male; NF-kappa B; Nitric Oxide Synthase Type III; Norepinephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; Shock, Septic; Up-Regulation; Vasoconstrictor Agents | 2015 |
Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model.
Topics: Animals; Disease Models, Animal; Female; Gastrointestinal Tract; Microcirculation; Oral Mucosal Absorption; Propanolamines; Random Allocation; Shock, Septic; Sublingual Gland; Swine | 2015 |
Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Echocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Prospective Studies; Pulmonary Artery; Shock, Septic; Stroke Volume; Vasoconstrictor Agents | 2016 |
[Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock].
Topics: Aged; Aged, 80 and over; Arterial Pressure; Cardiac Output; Central Venous Pressure; Extravascular Lung Water; Female; Fluid Therapy; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Prospective Studies; Respiration, Artificial; Shock, Septic; Stroke Volume | 2015 |
Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock.
Topics: Animals; Chile; Dexmedetomidine; Heart Rate; Hemodynamics; Hyperlactatemia; Lactic Acid; Models, Animal; Propanolamines; Sheep; Shock, Septic | 2016 |
Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Blood Pressure; Cardiac Output; Heart Rate; Male; Propanolamines; Rats; Rats, Wistar; Shock, Septic; Vasomotor System | 2016 |
Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Female; Hemodynamics; Infusions, Intravenous; Lipopolysaccharides; Monitoring, Physiologic; Propanolamines; Prospective Studies; Shock, Septic; Swine | 2011 |